Skip to Main Content ›
FREE Shipping on orders over $49
15% OFFCoupon Code:
SAVE15
100% Satisfaction Guaranteed
 15% OFF w/code
SAVE15
FREE Shipping $49+
100% Satisfaction Guaranteed
My Account
1800PetMeds® Press Releases
Call Us: 1-800-738-6337
11.05.2002
 
PETMED EXPRESS D/B/A 1-800-PetMedsŪ ANNOUNCES SECOND QUARTER RESULTS WITH RECORD REORDER SALES

Pompano Beach, Florida, November 5, 2002 - PetMed Express, Inc. (OTCBB: PETS) today announced results for the quarter ended September 30, 2002. Net sales for the quarter ended September 30, 2002 was $14.2 million, compared to $7.8 million for the quarter ended September 30, 2001, an increase of 83%. Net sales for the six months ended September 30, 2002 was $29.1 million, compared to $13.1 million for the six months ended September 30, 2001, an increase of 121%. Net income was $205,000 or $.01 per share, for the second quarter of fiscal 2003, compared to net income of $393,000 or $.02 per share for the second quarter of fiscal 2002. Net income for the six months ended September 30, 2002 was $1,107,000 or $.07 per share, $.05 diluted per share, compared to a net loss of $697,000 or $.04 loss per share for the six months ended September 30, 2001.

PetMed Express also reported new customer growth of approximately 114,000 customers for the second quarter of fiscal 2003, with 47% of those new customers ordering through our website at www.1800PetMeds.com.

Mendo Akdag, CEO, announced, "We are pleased with our continued sales growth and with our strong customer reorder sales. Our customer reorder sales have increased $8,496,000, or 234%, to $12,123,000 for the six months ended September 30, 2002, from $3,627,000 for the six months ended September 30, 2001. We spent 27% of our revenues on advertising, branding our 1-800-PetMedsŪ name for the quarter ending September 30, 2002, compared with 19% for the same period prior year. We believe branding our 1-800-PetMedsŪ name is critical for our long term success and profitability.

"In October 2002, the Company submitted an application for listing on the American Stock Exchange. We are excited with the prospect of greater visibility that listing on a major exchange delivers to the Company and our shareholders. The application is presently in the review stage, and no assurances can be made that the Company will be accepted for listing."

Founded in 1996, PetMed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications, and health and nutritional supplements at competitive prices through the PetMed Express catalog, customer service representatives, and on the Internet through its website at www.1800PetMeds.com.

This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risk and uncertainties, including the Company's ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such "forward-looking" statements are set forth in Management's Discussion and Analysis of Results of Financial Condition and Results of Operations in PetMed Express' Annual Report on Form 10K for the year ended March 31, 2002.

For investment relations contact PetMed Express, Inc., Pompano Beach, Florida, Mendo Akdag, CEO, 954-979-5995.

                 PETMED EXPRESS, INC. AND SUBSIDIARIES                         FINANCIAL HIGHLIGHTS            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS                              (UNAUDITED)                       Three Months Ended        Six Months Ended                         September 30,             September 30,                        2002         2001        2002         2001                    ------------ ----------- ------------ ------------ Sales              $14,229,702  $7,762,825  $29,060,457  $13,126,475 Cost of sales        8,029,410   4,681,379   16,597,663    8,132,268                    ------------ ----------- ------------ ------------ Gross profit         6,200,292   3,081,446   12,462,794    4,994,207                    ------------ ----------- ------------ ------------ Operating expenses:  General and   administrative     1,974,189   1,497,590    4,057,612    2,650,107  Advertising         3,832,241   1,437,810    6,639,421    2,785,463  Severance charges           -           -            -      195,000  Depreciation and   amortization          86,108      89,800      166,772      188,156                    ------------ ----------- ------------ ------------ Total operating  expenses            5,892,538   3,025,200   10,863,805    5,818,726                    ------------ ----------- ------------ ------------ Income (loss) from  operations            307,754      56,246    1,598,989     (824,519)                    ------------ ----------- ------------ ------------ Other income  (expense):  Adjustment of   estimate for   legal settlement           -     345,000            -      345,000  Loss on disposal   of property and   equipment                  -           -            -     (185,374)  Interest expense       (4,450)     (8,985)     (10,040)     (41,045)  Interest income         1,824       4,934        5,957       12,449  Other, net                952      (3,817)       3,287       (3,817)                    ------------ ----------- ------------ ------------ Total other income  (expense)              (1,674)    337,132         (796)     127,213                    ------------ ----------- ------------ ------------ Income (loss)  before provision  for income taxes      306,080     393,378    1,598,193     (697,306) Provision for  income taxes          101,193           -      490,977            -                    ------------ ----------- ------------ ------------ Net income (loss)     $204,887    $393,378   $1,107,216    $(697,306)                    ============ =========== ============ ============ Net income (loss)  per common share:   Basic                  $0.01       $0.02        $0.07       $(0.04)                    ============ =========== ============ ============   Diluted                $0.01       $0.02        $0.05       $(0.04)                    ============ =========== ============ ============ Weighted average  common shares  outstanding:   Basic             17,173,499  16,360,010   16,883,731   16,360,010                    ============ =========== ============ ============   Diluted           21,356,196  18,101,946   20,655,407   16,360,010                    ============ =========== ============ ============                          BALANCE SHEET DATA                              (UNAUDITED)                     Sept. 30,    Sept. 30,                       2002         2001                    ------------ ----------- Working capital  (deficiency)        1,195,126    (964,727) Total assets         7,805,963   3,652,785 Total liabilities    4,643,724   3,592,804 Total shareholders'  equity              3,162,239      59,981


 
Get 10% OFF Now Offer
Close
Live Chat Share Website Feedback